Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31,677Revenue $M2,105Net Margin (%)20.2Z-Score19.3
Enterprise Value $M31,558EPS $3.8Operating Margin %36.1F-Score4
P/E(ttm))87.1Cash Flow Per Share $-2.0Pre-tax Margin (%)33.9Higher ROA y-yN
Price/Book14.410-y EBITDA Growth Rate %0Quick Ratio5.9Cash flow > EarningsY
Price/Sales15.45-y EBITDA Growth Rate %0Current Ratio6.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %42.4ROA % (ttm)14.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)21.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M101ROI % (ttm)53.3Gross Margin Increase y-yN

Gurus Latest Trades with REGN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
REGNVanguard Health Care Fund 2014-06-30 Add0.79%$277.29 - $313.74
($296.6)
$ 322.189%Add 60.34%2,795,500
REGNVanguard Health Care Fund 2014-03-31 Add0.29%$267.62 - $347.62
($306.26)
$ 322.185%Add 23.47%1,743,468
REGNFrank Sands 2014-03-31 Add0.22%$267.62 - $347.62
($307.2)
$ 322.185%Add 7.48%4,012,062
REGNRon Baron 2014-03-31 Buy 0.01%$267.62 - $347.62
($307.2)
$ 322.185%New holding, 6084 sh.6,084
REGNJoel Greenblatt 2013-12-31 Sold Out -0.03%$261.88 - $313.67
($287.35)
$ 322.1812%Sold Out0
REGNFrank Sands 2013-09-30 Add0.56%$227.65 - $309.174
($262.76)
$ 322.1823%Add 20.34%3,777,357
REGNJoel Greenblatt 2013-09-30 Buy 0.03%$227.65 - $309.174
($262.76)
$ 322.1823%New holding, 3285 sh.3,285
REGNRay Dalio 2013-09-30 Sold Out -0.01%$227.65 - $309.174
($262.76)
$ 322.1823%Sold Out0
REGNFrank Sands 2013-06-30 Add1.07%$178.51 - $282.8
($232.86)
$ 322.1838%Add 81.03%3,138,793
REGNRay Dalio 2013-06-30 Buy 0.01%$178.51 - $282.8
($232.86)
$ 322.1838%New holding, 4100 sh.4,100
REGNVanguard Health Care Fund 2013-03-31 Add0.62%$158.42 - $183.77
($171.66)
$ 322.1888%Add 170.41%1,412,100
REGNFrank Sands 2013-03-31 Reduce-1.02%$158.42 - $183.77
($171.66)
$ 322.1888%Reduce -46.22%1,733,896
REGNFrank Sands 2012-09-30 Reduce-1.2%$112.77 - $152.66
($135.2)
$ 322.18138%Reduce -37.57%3,834,373
REGNVanguard Health Care Fund 2012-09-30 Reduce-0.09%$112.77 - $152.66
($135.2)
$ 322.18138%Reduce -24.56%522,200
REGNFrank Sands 2012-06-30 Add0.2%$108.78 - $143.87
($125.43)
$ 322.18157%Add 6.5%6,142,048
REGNDodge & Cox 2012-03-31 Sold Out $57.83 - $119.96
($92.23)
$ 322.18249%Sold Out0
REGNCarl Icahn 2011-09-30 Sold Out -1.76%$44.96 - $72.19
($58.66)
$ 322.18449%Sold Out0
REGNDodge & Cox 2011-09-30 Reduce-0.03%$44.96 - $72.19
($58.66)
$ 322.18449%Reduce -97.62%9,400
REGNDodge & Cox 2011-03-31 Buy 0.02%$32.61 - $44.68
($36.41)
$ 322.18785%New holding, 375685 sh.375,685
REGNSeth Klarman 2011-03-31 Sold Out $32.61 - $44.68
($36.41)
$ 322.18785%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

REGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
REGN Vanguard Health Care Fund 2014-06-302,795,5002.772.1+60.34%
REGN Ron Baron 2014-03-316,0840.010.01New Buy
REGN Frank Sands 2014-03-314,012,0623.983.1+7.48%
Premium Most recent portfolio changes are included for Premium Members only!


REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2014-07-15Buy129,100$314.922.31view
Sanofi10% Owner 2014-07-14Buy300,000$316.81.7view
Sanofi10% Owner 2014-07-10Buy175,000$311.083.57view
Sanofi10% Owner 2014-07-09Buy348,000$309.764.01view
Sanofi10% Owner 2014-07-07Buy356,700$312.373.14view
Sanofi10% Owner 2014-07-02Buy212,400$307.254.86view
Sanofi10% Owner 2014-07-01Buy212,400$300.27.32view
Sanofi10% Owner 2014-06-30Buy262,400$281.1714.59view
Van Plew Daniel PSVP & General Mgr Industrial O 2014-05-23Sell5,369$295.938.87view
POON CHRISTINE ADirector 2014-05-21Buy255$291.910.37view

Press Releases about REGN :

    Quarterly/Annual Reports about REGN:

    News about REGN:

    Articles On GuruFocus.com
    Weekly Insider Sells Highlight: MSFT, REGN, ATVI, MAA Feb 17 2014 
    Insiders Are Buying Ophthotech Oct 08 2013 
    Weekly Top Insider Sells: REGN May 27 2013 
    comment on REGN Mar 06 2013 
    Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
    52-Week High Companies: ZMH, CVX, V, REGN, DFS Sep 10 2012 
    Regeneron Pharmaceuticals: Continuous loss making company delivers 2-year 600% gain in share price Sep 08 2012 
    52-Week High Companies: BAM, REGN, TRV, WFC Aug 20 2012 
    52-Week High Companies: EC, MAT, ORLY, V, REGN Apr 16 2012 
    Weekly Top Insider Sells: TJX, MON, REGN, and PNC Jan 16 2012 


    More From Other Websites
    [$$] Drug Firms Buy $67.5 Million Voucher to Speed FDA Review Jul 30 2014
    Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission Jul 30 2014
    Regeneron's Eylea Gets FDA Nod for Diabetic Macular Edema Jul 30 2014
    Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints Jul 30 2014
    Stocks End Mixed; Akamai Falls, Yelp Rises After Hours Jul 30 2014
    US STOCKS-S&P 500, Nasdaq end up as Fed in no rush to raise rates Jul 30 2014
    US STOCKS-S&P 500, Nasdaq end up as Fed in no rush to raise rates Jul 30 2014
    4:05 pm Regeneron Pharms and Sanofi (SNY) announce plan to use... Jul 30 2014
    Sanofi and Regeneron Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission Jul 30 2014
    Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission Jul 30 2014
    US STOCKS-S&P 500 nearly flat as investors digest Fed statement Jul 30 2014
    US STOCKS-S&P 500 nearly flat as investors digest Fed statement Jul 30 2014
    US STOCKS-S&P 500 turns higher after Fed statement Jul 30 2014
    US STOCKS-S&P 500 turns higher after Fed statement Jul 30 2014
    Edwards, Hospira rise as health-care companies see strong earnings Jul 30 2014
    Amgen Restructuring Plan, Q2 Earnings Send Stock Up Jul 30 2014
    Regeneron shares jump after cholesterol drug meets test goals Jul 30 2014
    Jim Cramer's Mad Dash: Good News for Regeneron Jul 30 2014
    Stocks Thrash Out A Mixed Open; Buffalo Wild Wings Crumples Jul 30 2014
    Cramer: These 2 biotech stocks are going higher Jul 30 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide